US Patent

US10464938 — Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3â²,4â²:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof

Formulation · Assigned to Intra Cellular Therapies Inc · Expires 2028-03-12 · 2y remaining

Vulnerability score 63/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pharmaceutical compositions containing a specific type of heterocycle fused gamma-carboline compound, as defined in the patent.

USPTO Abstract

The present invention provides pharmaceutical compositions comprising certain optionally substituted heterocycle fused gamma-carbolines of Formula 2J, as shown below, and as further defined herein:

Drugs covered by this patent

lumateperone-tosylate (LUMATEPERONE TOSYLATE)

Patent Metadata

Patent number: US10464938
Jurisdiction: US
Classification: Formulation
Expires: 2028-03-12
Drug substance claim: No
Drug product claim: Yes
Assignee: Intra Cellular Therapies Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.